Half Year 2023 Biocon Ltd Earnings Call Transcript

Nov 15, 2022 / NTS GMT
Saurabh Paliwal - Biocon Limited - Head of IR

Good morning, everyone. I'm Saurabh Paliwal from Biocon's Investor Relations team, and I would like to welcome you to this earnings call for the second quarter of fiscal '23. (Operator Instructions) Please note that the chat box in the Zoom application is disabled, but you can raise any technical concerns by sending us an e-mail to [email protected]. Please note that this conference is being recorded. A recording will be made available on our website within a day and the transcript of the call shall be made available subsequently.

Today, to discuss the company's business performance and outlook for the quarter we have Dr. Kiran Mazumdar-Shaw, our Executive Chairperson; Mr. Siddharth Mittal, CEO and MD of Biocon Limited; along with other senior management colleagues across the business segments, including Generics, Biosimilars and Research Services.

Before we begin, I want to remind everyone about the safe harbor related to today's earnings call. Comments made during the call may be forward-looking in nature based on management's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot